| |
Alendronate (n=12) |
Control (n=12) |
| Age (yr) |
70.4±5.4 |
70.1±6.4 |
| BMI (kg/m2) |
23.8±4.2 |
24.1±3.5 |
| Treatment of diabetes |
| Diet |
1 |
1 |
| OHA |
5 |
6 |
| Insulin |
6 |
5 |
| HbA1c (%) |
7 6±1 4 |
7 3±1 5 |
| Duration |
13.1±3.9 |
12.8±2.4 |
| Urinary NTx (nmol BCE/mmol Cr) |
68.7±12.5 |
60.3±13.2 |
| BMD (g/cm2) |
0.296±0.066 |
0.318±0.041 |
OHA: oral hypoglycemic agent, BMD: bone mineral density |
